Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Brunner

Showing results (481-490 of 564) with videos related to

Pageof 57
Sort By:
Journal of Cardiovascular Pharmacology|July 1, 1983
CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteersB Jacot des Combes, G A Turini, H R Brunner, et al.
Deutsche Medizinische Wochenschrift (1946)|August 5, 1994
[Increased vascular sensitivity to nitroglycerin in patients with hypercholesterolemia and peripheral endothelial dysfunction]T Münzel, D Hayoz, B Hornig, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 1998
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin systemL Mazzolai, J Nussberger, J F Aubert, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824AJ Nussberger, M de Gasparo, L Juillerat, et al.
British Journal of Clinical Pharmacology|December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteersM Burnier, G A Turini, H R Brunner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 1999
Coronary and peripheral artery remodeling in patients undergoing PTCA: An intracoronary and transcutaneous ultrasound studyE Delacrétaz, M Fleisch, U P Kaufmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2000
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptorsC Pellieux, T Sauthier, A Domenighetti, et al.
Journal of Hypertension|January 1, 1990
Prevention of renal hypertension in the rat by neuropeptide YB Waeber, D Evéquoz, J F Aubert, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjectsJ P Bussien, T F d'Amore, L Perret, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 9, 1999
Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthaseJ A Haefliger, P Meda, A Formenton, et al.
Pageof 57

Showing results (481-490 of 564) with videos related to

Sort By:
Pageof 57
Journal of Cardiovascular Pharmacology|July 1, 1983
CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteersB Jacot des Combes, G A Turini, H R Brunner, et al.
Deutsche Medizinische Wochenschrift (1946)|August 5, 1994
[Increased vascular sensitivity to nitroglycerin in patients with hypercholesterolemia and peripheral endothelial dysfunction]T Münzel, D Hayoz, B Hornig, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 1998
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin systemL Mazzolai, J Nussberger, J F Aubert, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824AJ Nussberger, M de Gasparo, L Juillerat, et al.
British Journal of Clinical Pharmacology|December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteersM Burnier, G A Turini, H R Brunner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 1999
Coronary and peripheral artery remodeling in patients undergoing PTCA: An intracoronary and transcutaneous ultrasound studyE Delacrétaz, M Fleisch, U P Kaufmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2000
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptorsC Pellieux, T Sauthier, A Domenighetti, et al.
Journal of Hypertension|January 1, 1990
Prevention of renal hypertension in the rat by neuropeptide YB Waeber, D Evéquoz, J F Aubert, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjectsJ P Bussien, T F d'Amore, L Perret, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 9, 1999
Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthaseJ A Haefliger, P Meda, A Formenton, et al.
Pageof 57